Wnt3a and CHIR99021 did not alter the amount of neurites in ALS MNs (Figure 9(a2,a3), but they reversed the therapeutic function of IGF-1 (Figure 9(a6)) and showed negative effects of GSK3β inhibition on ALS MN neurite extension. Here, WNT3A is linked to amyotrophic lateral sclerosis.